[Special] Antengene targets Korean oncology market with first-in-class drugs

Press/Media: Research

Period	Jun 24 2022

Media coverage

Title	[Special] Antengene targets Korean oncology market with first-in-class drugs
Media name/outlet	Korea Biomedical Review
Date	6/24/22
URL	www.koreabiomed.com/news/articleView.html?idxno=13974
Persons	Young Kwon